Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission.

BACKGROUND Therapeutic control of HIV replication reduces the size of the viral reservoir, particularly among central memory CD4+ T cells, and this effect might be accentuated by early treatment. METHODS We examined the effect of ART initiated at the time of the primary HIV infection (early ART), lasting 2 and 6 years in 11 and 10 patients, respectively, on the HIV reservoir in peripheral resting CD4+ T cells, sorted into naive (TN), central memory (TCM), transitional memory (TTM) and effector memory (TEM) cells, by comparison with 11 post-treatment controllers (PTCs). RESULTS Between baseline and 2 years, CD4+ T cell subset numbers increased markedly (P < 0.004) and HIV DNA levels decreased in all subsets (P < 0.009). TTM cells represented the majority of reservoir cells at both timepoints, T cell activation status normalized and viral diversity remained stable over time. The HIV reservoir was smaller after 6 years of early ART than after 2 years (P < 0.019), and did not differ between PTCs and patients treated for 6 years. One patient, who had low reservoir levels in all T cell subsets after 2 years of treatment similar to the levels in PTCs, spontaneously controlled viral replication during 18 months off treatment. CONCLUSIONS Early prolonged ART thus limits the size of the HIV reservoir, protects long-lived cells from persistent infection and may enhance post-treatment control.

[1]  C. Katlama,et al.  Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial. , 2015, The Lancet. Infectious diseases.

[2]  E. Botelho-nevers,et al.  P-07: L’optimisation T2A du codage PMSI pénalise-t-elle le reflet de l’activité médicale d’un service des maladies infectieuses et tropicales ? , 2014 .

[3]  Sarah B. Laskey,et al.  Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure , 2013, Cell.

[4]  C. Katlama,et al.  A Single HIV-1 Cluster and a Skewed Immune Homeostasis Drive the Early Spread of HIV among Resting CD4+ Cell Subsets within One Month Post-Infection , 2013, PloS one.

[5]  C. Rouzioux,et al.  Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts. , 2013, The Journal of antimicrobial chemotherapy.

[6]  G. Carcelain,et al.  Direct Quantification of Cell-Associated HIV DNA in Isolated Rectal and Blood Memory CD4 T Cells Revealed Their Similar and Low Infection Levels in Long-Term Treated HIV-Infected Patients , 2013, Journal of acquired immune deficiency syndromes.

[7]  Brigitte Autran,et al.  Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study , 2013, PLoS pathogens.

[8]  R. Siliciano,et al.  Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies , 2013, PLoS pathogens.

[9]  Steve Kaye,et al.  Short-course antiretroviral therapy in primary HIV infection. , 2013, The New England journal of medicine.

[10]  D. Richman,et al.  Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. , 2013, The New England journal of medicine.

[11]  A. Perelson,et al.  Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection , 2012, Proceedings of the National Academy of Sciences.

[12]  G. Carcelain,et al.  Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  Jerome H. Kim,et al.  Impact of Multi-Targeted Antiretroviral Treatment on Gut T Cell Depletion and HIV Reservoir Seeding during Acute HIV Infection , 2012, PloS one.

[14]  H. Schuitemaker,et al.  No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial , 2012, PLoS medicine.

[15]  H. Günthard,et al.  Early Antiretroviral Therapy During Primary HIV-1 Infection Results in a Transient Reduction of the Viral Setpoint upon Treatment Interruption , 2011, PloS one.

[16]  Wei Shao,et al.  Majority of CD4+ T cells from peripheral blood of HIV-1–infected individuals contain only one HIV DNA molecule , 2011, Proceedings of the National Academy of Sciences.

[17]  T. Shirasaka,et al.  Cellular HIV-1 DNA levels in patients receiving antiretroviral therapy strongly correlate with therapy initiation timing but not with therapy duration , 2011, BMC infectious diseases.

[18]  B. Haynes,et al.  Acute HIV-1 Infection. , 2011, The New England journal of medicine.

[19]  B. Berkhout,et al.  Altered dynamics and differential infection profiles of lymphoid and myeloid cell subsets during acute and chronic HIV‐1 infection , 2011, Journal of leukocyte biology.

[20]  G. Carcelain,et al.  Immune reconstitution after a decade of combined antiretroviral therapies for human immunodeficiency virus. , 2011, Trends in immunology.

[21]  M. Proschan,et al.  B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy. , 2010, Blood.

[22]  Thierry Prazuck,et al.  Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection , 2010, AIDS.

[23]  M. Prins,et al.  Transient lowering of the viral set point after temporary antiretroviral therapy of primary HIV type 1 infection. , 2010, AIDS research and human retroviruses.

[24]  C. Rouzioux,et al.  Despite being highly diverse, immunovirological status strongly correlates with clinical symptoms during primary HIV-1 infection: a cross-sectional study based on 674 patients enrolled in the ANRS CO 06 PRIMO cohort. , 2010, The Journal of antimicrobial chemotherapy.

[25]  Mario Roederer,et al.  Immunologic and virologic events in early HIV infection predict subsequent rate of progression. , 2010, The Journal of infectious diseases.

[26]  Geneviève Boucher,et al.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation , 2009, Nature Medicine.

[27]  T. Chun,et al.  High frequencies of resting CD4+ T cells containing integrated viral DNA are found in rhesus macaques during acute lentivirus infections , 2009, Proceedings of the National Academy of Sciences.

[28]  Avettand‐Fènoël Véronique,et al.  LTR real‐time PCR for HIV‐1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01) , 2009 .

[29]  C. Rouzioux,et al.  HIV-DNA in rectal cells is well correlated with HIV-DNA in blood in different groups of patients, including long-term non-progressors , 2008, AIDS.

[30]  Amalio Telenti,et al.  Antiretroviral Treatment of Adult HIV Infection2010 Recommendations of the International AIDS Society–USA Panel , 2010 .

[31]  S. Mehandru,et al.  Role of the gastrointestinal tract in establishing infection in primates and humans , 2008, Current opinion in HIV and AIDS.

[32]  Lawrence Corey,et al.  Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus. , 2007, The Journal of infectious diseases.

[33]  Asier Sáez-Cirión,et al.  HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype , 2007, Proceedings of the National Academy of Sciences.

[34]  J. Kaldor,et al.  Effect of Transient Antiretroviral Treatment during acute HIV Infection: Comparison of the Quest Trial Results with CASCADE Natural History Study , 2007, Antiviral therapy.

[35]  C. Rouzioux,et al.  Structured Treatment Interruptions in Primary HIV-1 Infection: The ANRS 100 PRIMSTOP Trial , 2005, Journal of acquired immune deficiency syndromes.

[36]  Matthew C Strain,et al.  Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. , 2005, The Journal of infectious diseases.

[37]  Mario Roederer,et al.  Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection , 2005, Nature.

[38]  E. Rosenberg,et al.  Limited Durability of Viral Control following Treated Acute HIV Infection , 2004, PLoS medicine.

[39]  Marc K Hellerstein,et al.  Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection. , 2003, The Journal of clinical investigation.

[40]  Michael P Busch,et al.  Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection , 2003, AIDS.

[41]  E. Rosenberg,et al.  Immune control of HIV-1 after early treatment of acute infection , 2000, Nature.

[42]  T V Perneger,et al.  Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia , 2000, AIDS.

[43]  T. Chun,et al.  Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  R P Johnson,et al.  Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. , 1998, Science.

[45]  S. Hammer,et al.  Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. , 1997, JAMA.

[46]  E. G. Shpaer,et al.  Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. , 1993, Science.

[47]  M. Kimura.  A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences , 1980, Journal of Molecular Evolution.

[48]  C. Rouzioux,et al.  LTR Real-Time PCR for HIV-1 DNA Quantitation in Blood Cells for Early Diagnosis in Infants Born to Seropositive Mothers Treated in HAART Area ( ANRS CO 01 ) , 2008 .

[49]  Douglas D. Richman,et al.  Antiretroviral Treatment of Adult HIV Infection , 2008 .

[50]  F. Bahri,et al.  La tuberculose ganglionnaire: Etude de 24 cas observés dans un service de médecine interne et maladies infectieuses , 2002 .